Clinical trial
TRADE-Testosterone Replacement and Dutasteride Effectiveness
NCT00194675 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00194675 |
|---|---|
| Title | TRADE-Testosterone Replacement and Dutasteride Effectiveness |
| Official title | Testosterone Replacement and Dutasteride Effectiveness (TRADE) |
| Acronym | TRADE |
| Lead sponsor | University of Washington, Other |
| Collaborators | GlaxoSmithKline Industry Seattle Institute for Biomedical and Clinical Research VA Office of Research and Development U.S. Fed Solvay Pharmaceuticals |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypogonadism, Benign Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Dutasteride, Testosterone gel, Placebo dutasteride |
| Enrollment | 53 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: